NASDAQ:RXDX
Prometheus Biosciences, Inc.
- Stock
Last Close
199.74
15/06 20:00
Market Cap
9.56B
Beta: −0.60
Volume Today
1.79M
Avg: 983.04K
PE Ratio
−63.62
PFCF: −88.63
Dec '14 | Dec '15 | Dec '16 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|
revenue | 150K - | 1.12M - | 1.23M 9.93% | 3.13M 154.60% | 6.81M 117.61% | |||
cost of revenue | ||||||||
gross profit | 150K - | 1.12M - | 1.23M 9.93% | 3.13M 154.60% | 6.81M 117.61% | |||
selling and marketing expenses | ||||||||
general and administrative expenses | 9.49M - | 17.07M 79.80% | 23.76M 39.19% | 6.13M 74.21% | 11.09M 80.96% | 28.50M 157.06% | 39.74M 39.41% | |
selling general and administrative expenses | 9.49M - | 17.07M 79.80% | 23.76M 39.19% | 6.13M 74.21% | 11.09M 80.96% | 28.50M 157.06% | 39.74M 39.41% | |
research and development expenses | 30.51M - | 73.51M 140.98% | 76.93M 4.65% | 10.96M 85.76% | 19.15M 74.73% | 62.43M 226.04% | 112.85M 80.77% | |
other expenses | -15K - | -2.39M 15,846.67% | 4.03M 268.31% | |||||
cost and expenses | 40.00M - | 90.58M 126.46% | 100.68M 11.15% | 17.09M 83.03% | 30.24M 76.96% | 90.93M 200.74% | 152.59M 67.80% | |
operating expenses | 40.00M - | 90.58M 126.46% | 100.68M 11.15% | 17.09M 83.03% | 30.24M 76.96% | 90.93M 200.74% | 152.59M 67.80% | |
interest expense | 2.59M - | 3.21M 23.95% | 770K 76.04% | 2.13M 176.62% | 861K 59.58% | |||
ebitda | -39.45M - | -87.83M 122.63% | -96.95M 10.38% | -15.92M 83.57% | -28.90M 81.49% | -87.80M 203.82% | -145.78M 66.03% | |
operating income | -39.85M - | -90.58M 127.31% | -100.68M 11.15% | -15.97M 84.14% | -29.01M 81.66% | -87.80M 202.70% | -145.78M 66.03% | |
depreciation and amortization | 527.67K - | 2.04M 286.03% | 3.48M 70.74% | 44K 98.73% | 107K 143.18% | 258K 141.12% | 629K 143.80% | |
total other income expenses net | -128.42K - | -1.88M 1,362.38% | -2.96M 57.35% | -761K 74.25% | -2.13M 180.16% | -2.39M 12.20% | 4.03M 268.31% | |
income before tax | -39.98M - | -92.46M 131.28% | -103.64M 12.09% | -16.73M 83.86% | -31.14M 86.14% | -90.19M 189.65% | -141.75M 57.16% | |
income tax expense | 12.33K - | 715K 5,698.86% | 259K 63.78% | 13.76M 5,214.29% | 8.11M 41.05% | -258K 103.18% | -629K 143.80% | |
net income | -39.99M - | -92.46M 131.20% | -103.64M 12.09% | -30.49M 70.58% | -39.25M 28.73% | -89.94M 129.12% | -141.75M 57.61% | |
weighted average shs out | 18.33M - | 26.85M 46.52% | 38.48M 43.29% | 26.98M 29.87% | 34.61M 28.25% | 31.33M 9.46% | 40.62M 29.63% | |
weighted average shs out dil | 18.33M - | 26.85M 46.52% | 38.48M 43.29% | 26.98M 29.87% | 34.61M 28.25% | 31.33M 9.46% | 40.62M 29.63% | |
eps | -2.18 - | -3.44 57.80% | -2.69 21.80% | -1.13 57.99% | -1.13 0% | -2.87 153.98% | -3.49 21.60% | |
epsdiluted | -2.18 - | -3.44 57.80% | -2.69 21.80% | -1.13 57.99% | -1.13 0% | -2.87 153.98% | -3.49 21.60% |
All numbers in USD (except ratios and percentages)